Table 2 Distribution of TLS patients grouped by WBC count.
From: Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
WBC < 50 × 109/L (n = 36, %) | WBC ≥ 50 × 109/L (n = 43, %) | OR (95% CI) | |
|---|---|---|---|
Age | |||
≥ 1 | 97.2 | 86.0 | 1.00 |
< 1 | 2.8 | 14.0 | 5.7 (0.7–49.6) |
Sex | |||
Female | 33.3 | 25.6 | 1.00 |
Male | 66.7 | 74.4 | 1.5 (0.5–3.9) |
Extramedullary infiltrationa | |||
No | 91.7 | 83.7 | 1.00 |
Yes | 8.3 | 16.3 | 2.1 (0.5–9.0) |
Immunophenotype | |||
B | 77.8 | 32.6 | 1.00 |
T | 22.2 | 67.4 | 7.3 (2.6–19.9) |
Hyperkalemia | |||
No | 75.0 | 55.8 | 1.00 |
Yes | 25.0 | 44.2 | 2.4 (0.9–6.2) |
Hyperphosphatemia | |||
No | 44.4 | 23.3 | 1.00 |
Yes | 55.6 | 76.7 | 2.6 (1.0–6.9) |
Hyperuricemia | |||
No | 38.9 | 48.8 | 1.00 |
Yes | 61.1 | 51.2 | 0.7 (0.3–1.6) |
Hypocalcemia | |||
No | 72.2 | 32.6 | 1.00 |
Yes | 27.8 | 67.4 | 5.4 (2.0–14.2) |
